價格 | 詢價 | ||
包裝 | 1支 | 1支 | 1支 |
最小起訂量 | 1支 |
發(fā)貨地 | 湖北 |
更新日期 | 2024-11-18 |
中文名稱:西妥木單抗 | 英文名稱:Research Grade Cixutumumab(DHC29904) |
CAS:947687-12-9 | 純度規(guī)格: PAGE:>95% |
產(chǎn)品類別: 藥物對照抗體 | |
抗體名: Cixutumumab | 靶點: CD221, Insulin-like growth factor 1 receptor, IGF1R, Insulin-like growth factor I receptor, IGF-I receptor |
宿主: Homo sapiens | 適應(yīng)物種: Human |
克隆性: Monoclonal | 藥物對照抗體: Cixutumumab |
Tags:Cixutumumab 代理商,Cixutumumab 價格,Cixutumumab 供應(yīng)商, Cixutumumab supplier,Cixutumumab purchase,Cixutumumab 購買,Cixutumumab 銷售
Catalog No.
DHC29904
Host species
Homo sapiens
Species reactivity
Human
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4.
Concentration
1 mg/ml
Purity
>95%
Clonality
Monoclonal
Isotype
IgG1-lambda
Applications
Research Grade Biosimilar
Target
CD221, Insulin-like growth factor 1 receptor, IGF1R, Insulin-like growth factor I receptor, IGF-I receptor
Purification
Protein A or G purified from cell culture supernatant.
Endotoxin level
Please contact with the lab for this information.
Expression system
XtenCHO
Accession
P08069
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
Alternative Names
IMC-A12, LY3012217, CAS: 947687-12-9
Note
For research use only. Not suitable for clinical or therapeutic use.
成立日期 | 2021-04-08 (4年) | 注冊資本 | 一千萬元人民幣 |
員工人數(shù) | 100-500人 | 年營業(yè)額 | ¥ 1000萬-5000萬 |
主營行業(yè) | 生物化工,技術(shù)服務(wù) | 經(jīng)營模式 | 試劑 |
產(chǎn)品名稱 | 價格 | 公司名稱 | 報價日期 | |
---|---|---|---|---|
詢價 |
VIP1年
|
湖南瑞威爾生物科技有限公司
|
2024-09-29 | |
¥526 |
VIP3年
|
湖北魏氏化學試劑股份有限公司
|
2024-10-07 | |
詢價 |
VIP3年
|
陜西締都醫(yī)藥化工有限公司
|
2024-10-29 |